Nerve pain was most common in lung cancer patients, affecting more than 62%. This is probably because these patients ...

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...

The following is a summary of “Pain Assessment and Management in Oncological Practice: A Survey from the Italian Network of ...

Platinum-based or taxane chemotherapy drugs appear to pose the greatest risk for nerve pain, and lung cancer patients seem to have the highest rates of neuropathy, results show. Chemo drugs kill ...